The Clinical and Molecular Characteristics of Community-Associated Staphylococcus aureus Bacteremia in Persons who Inject Drugs at a New York City Tertiary Care Facility During the Opioid Epidemic - Takeaways - MDSpire

The Clinical and Molecular Characteristics of Community-Associated Staphylococcus aureus Bacteremia in Persons who Inject Drugs at a New York City Tertiary Care Facility During the Opioid Epidemic

  • By

  • Sherif Shoucri

  • Nicholas J Blair

  • Dwayne Seeram

  • Angela Gomez-Simmonds

  • Qiuhu Shi

  • Franklin D Lowy

  • Anne-Catrin Uhlemann

  • May 21, 2025

  • 0 min

Share

  • 1

    The study analyzed community-associated Staphylococcus aureus bacteremia among injection drug users at a New York City medical center over two years.

  • 2

    Twenty-nine injection drug users with Staphylococcus aureus bacteremia were compared to 112 non-injection drug users with similar infections.

  • 3

    Injection drug users were younger, more unstably housed, and had higher rates of infective endocarditis compared to non-injection drug users.

  • 4

    Whole-genome sequencing revealed genetic diversity among Staphylococcus aureus isolates, with no specific clusters identified among injection drug users.

  • 5

    The findings suggest the need for targeted early multidisciplinary interventions for injection drug users to address higher rates of infective endocarditis.

Original Source(s)

Related Content